or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 193.33 -0.54% -1.05
    MDGL closed down 0.54 percent on Friday, April 26, 2024, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 7
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Multiple of Ten Bullish Other 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish -0.54%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Rose Above Lower Bollinger Band about 19 hours ago
    Fell Below Previous Day's Low about 19 hours ago
    Down 2 % about 19 hours ago
    Down 1% about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 Madrigal Statement on the Passing of Dr. Stephen Harrison
    Apr 24 Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage
    Apr 23 Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
    Apr 15 Latest Insider Selling in April 2024: 10 Stocks to Watch
    Apr 9 Madrigal announces US launch of NASH/MASH drug Rezdiffra
    Apr 9 Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
    Apr 5 Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
    Apr 4 Madrigal Pharmaceuticals Inc Director James Daly Sells 32,489 Shares
    Apr 4 Madrigal Pharmaceuticals Inc Director Richard Levy Sells 11,000 Shares
    Apr 4 Madrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 322.67
    52 Week Low 119.7604
    Average Volume 550,956
    200-Day Moving Average 201.56
    50-Day Moving Average 242.39
    20-Day Moving Average 230.29
    10-Day Moving Average 215.12
    Average True Range 13.20
    RSI (14) 28.57
    ADX 22.38
    +DI 12.99
    -DI 34.97
    Chandelier Exit (Long, 3 ATRs) 228.62
    Chandelier Exit (Short, 3 ATRs) 228.60
    Upper Bollinger Bands 266.83
    Lower Bollinger Band 193.74
    Percent B (%b) -0.01
    BandWidth 31.74
    MACD Line -12.63
    MACD Signal Line -7.98
    MACD Histogram -4.6493
    Fundamentals Value
    Market Cap 3.82 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -10.05
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 203.20
    Resistance 3 (R3) 202.85 199.22 201.56
    Resistance 2 (R2) 199.22 196.70 199.39 201.01
    Resistance 1 (R1) 196.27 195.15 197.75 196.62 200.46
    Pivot Point 192.64 192.64 193.37 192.81 192.64
    Support 1 (S1) 189.69 190.12 191.17 190.04 186.20
    Support 2 (S2) 186.06 188.57 186.23 185.65
    Support 3 (S3) 183.11 186.06 185.11
    Support 4 (S4) 183.46